RBC Life Sciences�
For immediate Release
May 18, 2011
RBC Life Sciences Granted Marketing Rights to Stem-Kine Supplement
Irving, Texas (RBC Life Sciences: OTCBB: RBCL) - RBC Life Sciences, Inc. announced that it has been granted a license to market Stem-Kine in North America and 36 other countries. Stem-Kine is a dietary supplement that nourishes a person�s bone marrow enabling it to increase the production of circulating adult stem cells.
Stem-Kine was developed by Dr. Neil Riordan based on a study of bone marrow metabolism and the production of adult stem cells. It is a combination of well-known natural nutrients made with a proprietary fermentation process.
In collaboration with a group of scientists in major universities and research organizations, a human clinical pilot study was conducted that showed a 100% increase in stem cell levels over a two-week period, as reported in a peer-reviewed medical journal.
Subsequently an 18-patient study was conducted that showed a 53% increase in CD34 type stem cells, and a 90% increase in CD133 type stem cells, both over a two-week period. This second study was also reported in a peer-reviewed medical journal, with the comment by the authors, �To our knowledge this is the first study demonstrating profound mobilization effect with possible clinical significance by a food supplement-based approach.�
RBC Life Sciences, Inc. is a 20-year-old public company based in Irving, Texas that markets a broad line of high quality nutritional products through its dietary supplement division, RBC Life.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
Contacts:
Steve Brown
972-893-4000
[email protected]